Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.
Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.
复制标题
联合使用褪黑激素和 9-顺式视黄酸可消退 NMU 诱导的乳腺肿瘤。
DOI:
10.1016/j.canlet.2005.01.005
复制
发表时间:
2005
期刊:
影响因子:
9.7
通讯作者:
Hill,SM
中科院分区:
文献类型:
--
作者:
Melancon,K;Cheng,Q;Kiefer,TL;Dai,J;Lai,L;Dong,C;Yuan,L;Collins,A;Thiyagarajah,A;Long,S;Hill,SM
A significant increase in tumor regression was induced in N-nitroso-N-methylurea-induced mammary tumors in rats treated with the combination of melatonin and 9-cis-retinoic acid (9cRA). Treatment groups included: control (ethanolic saline), 9cRA (30mg/kg chow/day), melatonin 500μg/day, melatonin 1000μg/day, melatonin 500μg/day+9cRA and melatonin 1000μg/day+9cRA. Rats treated with the lower dose of melatonin 500μg+9cRA show the greatest degree of tumor regression (78%), with 54% undergoing complete regression and a significant increase in apoptotic cells observed by TUNEL Assay. Furthermore, tumor multiplicity and burden were significantly decreased by the combination of melatonin and 9cRA.